SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-009364
Filing Date
2020-01-31
Accepted
2020-01-31 17:18:54
Documents
13
Period of Report
2020-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206403d1_8k.htm   iXBRL 8-K 31012
2 EXHIBIT 99.1 tm206403d1_ex99-1.htm EX-99.1 8756
  Complete submission text file 0001104659-20-009364.txt   219619

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhvn-20200131.xsd EX-101.SCH 3204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhvn-20200131_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhvn-20200131_pre.xml EX-101.PRE 22722
9 EXTRACTED XBRL INSTANCE DOCUMENT tm206403d1_8k_htm.xml XML 3659
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 20566013
SIC: 2834 Pharmaceutical Preparations